137 related articles for article (PubMed ID: 7127669)
1. Enhancement of methylnitrosourea skin carcinogenesis by inhibiting cell proliferation with hydroxyurea or skin extracts.
Iversen OH
Carcinogenesis; 1982; 3(8):881-9. PubMed ID: 7127669
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyurea enhances methylnitrosourea skin tumorigenesis when given shortly before, but not after, the carcinogen.
Iversen OH
Carcinogenesis; 1982; 3(8):891-4. PubMed ID: 7127670
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of methylnitrosourea-induced skin tumorigenesis and carcinogenesis in hairless mice by pretreatment with a mitosis-inhibiting epidermal pentapeptide.
Iversen OH; Elgjo K; Reichelt KL
Carcinogenesis; 1989 Feb; 10(2):241-4. PubMed ID: 2912574
[TBL] [Abstract][Full Text] [Related]
4. Carcinogenic doses of methylnitrosourea induce dose response related delay in transit through S and G2 phases in mouse epidermis: a cell kinetic study.
Kirkhus B; Iversen OH; Kristensen A
Carcinogenesis; 1987 Mar; 8(3):369-75. PubMed ID: 3815731
[TBL] [Abstract][Full Text] [Related]
5. A diurnal variation in the tumorigenic response of mouse epidermis to a single application of the strong short-acting chemical carcinogen methylnitrosourea. A dose-response study of 1, 2 and 10 mg.
Iversen OH; Iversen UM
In Vivo; 1995; 9(2):117-32. PubMed ID: 7548787
[TBL] [Abstract][Full Text] [Related]
6. Carcinogenicity and organ specificity of N-trimethylsilylmethyl-N-nitrosourea (TMS-MNU), N-neopentyl-N-nitrosourea (neoPNU), and N-methyl-N-nitrosourea (MNU) in rats.
Maekawa A; Onodera H; Kanno J; Furuta K; Nagaoka T; Todate A; Matsushima Y; Oh-hara T; Kawazoe Y
J Cancer Res Clin Oncol; 1988; 114(5):473-6. PubMed ID: 3182906
[TBL] [Abstract][Full Text] [Related]
7. Induction of skin and thyroid tumors in male rats by N-methyl-N-nitrosourea after sequential treatment with cyproterone acetate and testosterone propionate: effects of castration, rat strain and time of carcinogen injection.
Bosland MC; Prinsen MK; Rivenson A; Weisburger JH
Carcinogenesis; 1992 Apr; 13(4):669-74. PubMed ID: 1533574
[TBL] [Abstract][Full Text] [Related]
8. Circadian variation in the susceptibility of mouse epidermis to tumour induction by methylnitrosourea.
Clausen OP; Iversen OH; Thorud E
Virchows Arch B Cell Pathol Incl Mol Pathol; 1984; 45(3):325-9. PubMed ID: 6146223
[TBL] [Abstract][Full Text] [Related]
9. Reversible inhibition of rat hepatocyte proliferation by hydrocortisone and its effect on cell cycle-dependent hepatocarcinogenesis by N-methyl-N-nitrosourea.
Kaufmann WK; Kaufman DG; Rice JM; Wenk ML
Cancer Res; 1981 Nov; 41(11 Pt 1):4653-60. PubMed ID: 7306981
[TBL] [Abstract][Full Text] [Related]
10. Nitrosomethylurea (MNU): a powerful carcinogen for mouse skin. A study utilising the tetrazolium test (TZT) and topical skin applications.
Iversen OH
Virchows Arch B Cell Pathol Incl Mol Pathol; 1979 Jun; 30(3):363-5. PubMed ID: 43013
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects of methylnitrosourea on developing brain.
Fujimori K; Sunouchi M; Inoue K; Nakadate M; Takanaka A; Omori Y
Neurochem Res; 1983 Feb; 8(2):193-206. PubMed ID: 6190099
[TBL] [Abstract][Full Text] [Related]
12. The effect of isoprenaline on induction of tumours by methyl nitrosourea in the salivary and mammary glands of female wistar rats.
Parkin R; Neale S
Br J Cancer; 1976 Oct; 34(4):437-43. PubMed ID: 974007
[TBL] [Abstract][Full Text] [Related]
13. Hydroxyurea: possible relationship of cytotoxicity to inhibition of skin carcinogenesis.
Hennings H
J Natl Cancer Inst; 1971 Apr; 46(4):841-4. PubMed ID: 5573772
[No Abstract] [Full Text] [Related]
14. Promotion of N-methyl-N-nitrosourea-induced thyroid tumors by iodine deficiency in F344/NCr rats.
Ohshima M; Ward JM
J Natl Cancer Inst; 1984 Jul; 73(1):289-96. PubMed ID: 6588234
[TBL] [Abstract][Full Text] [Related]
15. DNA damaging and cell proliferative activity of 1-methyl-1-nitrosourea in rat glandular stomach mucosa.
Furihata C; Ikui E; Matsushima T
Mutat Res; 1995 Dec; 348(4):169-73. PubMed ID: 8544869
[TBL] [Abstract][Full Text] [Related]
16. Moderate enhancement of the promotion phase of skin tumorigenesis in hairless mice by topical pretreatment with a mitosis-inhibiting epidermal pentapeptide.
Iversen OH; Elgjo K; Paulsen JE; Reichelt KL
Carcinogenesis; 1993 Dec; 14(12):2537-42. PubMed ID: 8269624
[TBL] [Abstract][Full Text] [Related]
17. DNA damage and repair in embryonic mouse limbs exposed to teratogenic doses of methylnitrosourea.
Loch-Caruso R; Baxter CS
Mutat Res; 1984; 131(3-4):147-55. PubMed ID: 6717469
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune haemolytic disease in mice after exposure to a methylating carcinogen.
Harris G; Lawley PD; Asbery LJ; Chandler PM; Jones MG
Immunology; 1983 Jul; 49(3):439-49. PubMed ID: 6862520
[TBL] [Abstract][Full Text] [Related]
19. Carcinogenesis in heterotopically-transplanted urinary bladder by N-methyl-N-nitrosourea: a model for initiation and promotion.
Miyata Y; Babaya K; Oyasu R
Carcinogenesis; 1981; 2(6):495-7. PubMed ID: 7273329
[TBL] [Abstract][Full Text] [Related]
20. Effect of ovarian hormones on the induction of 1-methyl-1-nitrosourea-induced mammary cancer.
Grubbs CJ; Peckham JC; McDonough KD
Carcinogenesis; 1983; 4(4):495-7. PubMed ID: 6839422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
